Lifevantage Corporation

Lifevantage Corporation

LFVN · NASDAQ · Consumer Defensive / Packaged Foods

4.97USD-0.07 (-1.39%)

Price History

Full chart

Market Stats

Previous Close5.04
Open4.96
Day Range4.76 – 5.24
52-Week Range3.81 – 11.62
Volume111.50K
Market Cap77.93M
P/E (TTM)15.47
Forward P/E37.45
EPS0.40
Dividend Yield3.19%
Beta0.76
50-Day Avg6.42
200-Day Avg5.92

About

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; P84 System, a product activator consisting of PhytoPower 1 and PhytoPower 2 that contains probiotics, prebiotics, postbiotics, digestive enzymes, and superfood blends designed to support gut health; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMs. Michelle Oborn-Virchow
  • Employees209
  • Headquarters3300 North Triumph Boulevard, Lehi, UT, United States, 84043, USA
  • Websitehttps://www.lifevantage.com

Leadership

  • Ms. Michelle Oborn-VirchowChief People Officer · b. 1980

Financials

Income Statement

Currency: USD1997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue---11---2.35M7.17M5.05M3.20M4.14M11.48M38.92M126.18M208.18M213.97M190.34M206.54M199.49M203.20M225.96M232.91M220.18M206.36M213.40M200.16M228.53M182.59M
Growth (%)----0.00%----+204.44%-29.51%-36.64%+29.41%+177.17%+239.06%+224.22%+64.98%+2.78%-11.04%+8.51%-3.41%+1.86%+11.20%+3.08%-5.47%-6.28%+3.41%-6.20%+14.17%-20.10%
Cost of Revenue--------393.55K1.49M1.02M695.39K852.80K1.91M5.92M18.05M36.64M33.19M28.01M33.93M33.46M34.85M37.97M37.96M38.19M38.10M43.39M41.44M44.86M40.97M
Gross Profit---11---1.96M5.67M4.03M2.50M3.29M9.57M33.00M108.13M171.53M180.77M162.33M172.61M166.03M168.36M187.99M194.95M181.99M168.26M170.01M158.72M183.67M141.61M
Gross Margin---100.00%100.00%---83.28%79.19%79.75%78.27%79.41%83.40%84.80%85.69%82.40%84.49%85.28%83.57%83.23%82.85%83.19%83.70%82.66%81.54%79.67%79.30%80.37%77.56%
Operating Expense---15.20K24.73K---4.05M8.54M7.69M4.31M11.09M16.89M29.30M86.67M159.47M161.33M148.43M159.19M161.58M158.03M178.49M179.49M164.38M160.69M165.75M154.39M171.47M135.51M
Operating Income-19.84K-24.04K-78.71K-15.20K-24.73K-16.35K-9.41K-12.24K-2.08M-2.87M-3.66M-1.80M-7.81M-7.32M3.70M21.46M12.07M19.45M13.90M13.41M4.45M10.32M9.49M15.47M17.61M7.58M4.26M4.33M12.20M6.10M
Operating Margin----1520300.00%-2472900.00%----88.57%-40.04%-72.40%-56.33%-188.47%-63.79%9.51%17.00%5.80%9.09%7.30%6.49%2.23%5.08%4.20%6.64%8.00%3.67%2.00%2.16%5.34%3.34%
EBITDA-19.84K-24.04K-78.71K-15.20K-24.73K-16.35K-9.41K-12.24K1.64M-2.47M-3.56M-1.54M-7.61M-6.81M-44.49M15.24M12.81M21.95M16.02M13.90M5.12M11.33M11.45M19.88M20.71M7.96M7.84M7.93M15.40M8.84M
EBITDA Margin----1520300.00%-2472900.00%---69.76%-34.46%-70.57%-48.05%-183.80%-59.35%-114.32%12.08%6.16%10.26%8.42%6.73%2.57%5.58%5.07%8.54%9.41%3.86%3.67%3.96%6.74%4.84%
Net Income-19.84K-24.04K-78.71K-15.20K-24.73K-16.35K-9.43K-12.24K-5.82M-2.73M-3.69M-2.05M-9.11M-11.05M-50.79M12.47M7.61M11.38M6.99M6.02M1.61M5.76M7.43M11.55M12.89M3.12M2.54M2.94M9.80M5.07M
Net Income Margin----1520400.00%-2473000.00%----247.36%-38.16%-73.13%-64.20%-220.09%-96.25%-130.51%9.88%3.65%5.32%3.67%2.91%0.81%2.84%3.29%4.96%5.86%1.51%1.19%1.47%4.29%2.78%
R&D--------37.93K114.16K245.56K324.11K224.37K392.69K508.60K1.36M2.95M2.00M2.40M1.00M1.10M1.20M1.10M900.00K700.00K700.00K600.00K700.00K--
R&D as % of Total Revenue--------1.61%1.59%4.86%10.13%5.42%3.42%1.31%1.08%1.42%0.93%1.26%0.48%0.55%0.59%0.49%0.39%0.32%0.34%0.28%0.35%--
Interest Expense00000000000296.95B1.33M6.83M5.99M44.23K3.00K3.18M3.09M3.32M570.00K456.00K323.00K120.00K17.00K10.00K198.00K---
Interest Expense % of Total Revenue---0.00%0.00%---0.00%0.00%0.00%9279089.20%32.12%59.49%15.40%0.04%0.00%1.48%1.62%1.61%0.29%0.22%0.14%0.05%0.01%0.00%0.09%---

Balance Sheet

Currency: USD1997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets308.52K308.63K183.13K35.74K44.01K39.49K36.50K37.96K11.84M10.45M3.91M4.55M5.72M6.23M12.50M44.53M55.48M54.00M40.88M50.26M45.25M51.14M55.27M58.88M78.73M70.71M66.12M60.30M71.96M62.11M
Total Liabilities178.82K202.97K156.18K24.00K-1.33K6.78K14.47K865.20K2.16M1.20M1.38M12.57M22.40M33.31M16.24M21.54M50.01M37.55M38.13M30.72M29.20M28.07M25.62M41.92M39.19M31.47M34.31M37.32M28.52M
Total Equity129.70K105.66K26.95K11.74K44.01K38.16K29.72K23.49K10.98M8.28M2.71M3.17M-6.85M-16.17M-20.81M28.28M33.95M3.99M3.33M12.13M14.53M21.95M27.20M33.25M36.81M31.52M34.65M25.99M34.64M33.59M
Cash9111.02K215-8.27K3.75K7562.22K3.39M228.11K160.76K196.88K608.79K1.64M6.37M24.65M26.30M20.39M13.90M7.88M11.46M16.65M18.82M22.14M23.17M20.19M21.61M16.89M20.20M14.92M
Total Debt134.60K142.52K29.41K22.00K---10.00K-3.15K3.15K390.95K1.01M1.26M433.98K--29.77M21.63M9.50M7.44M5.41M1.45M1.18M18.18M15.76M13.09M13.61M11.68M9.87M
Net Debt133.69K141.50K29.19K22.00K-8.27K-3.75K-756-2.22K-3.39M-224.97K-157.61K194.07K396.33K-380.32K-5.94M-24.65M-26.30M9.39M6.87M1.53M-4.02M-11.24M-17.37M-20.95M-4.99M-4.43M-8.52M-3.27M-8.52M-5.05M

Cash Flow

Currency: USD1997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-1.38K111-807-127.38K-19.73K-15.02K-9.99K-3.04K-2.91M-915.63K-3.13M-747.78K-5.21M-4.50M4.68M19.39M10.66M12.11M13.22M6.04M6.60M13.26M17.79M18.33M7.96M7.96M6.83M12.20M11.88M10.24M
Investing Cash Flow---147.17K-----552.65K-3.26M3.06M-1.17M204.49K178.30K-89.00K-1.90M-5.08M-2.25M-1.16M-562.00K-1.05M-4.65M-4.51M-2.68M-1.53M-1.53M-3.06M-2.25M-1.37M-7.31M
Financing Cash Flow----20.00K28.00K10.50K7.00K4.50K6.80M-1.17K-1.83K1.95M5.41M5.38M169.00K746.00K-4.02M-15.80M-18.45M-11.70M-1.96M-3.50M-11.12M-12.42M-8.95M-8.95M-2.36M-14.42M-7.60M-7.78M
Capital Expenditure0000000059.06K136.37K60.17K70.30K245.51K46.70K164.00K2.25M5.08M2.25M1.16M562.00K1.05M4.65M2.51M2.68M1.53M1.53M3.07M2.25M1.37M3.57M
Free Cash Flow-1.38K111-807-127.38K-19.73K-15.02K-9.99K-3.04K-2.97M-1.05M-3.19M-818.08K-5.45M-4.55M4.52M17.14M5.58M9.86M12.06M5.47M5.54M8.61M15.28M15.64M6.43M6.43M3.76M9.95M10.51M6.67M
Dividends Paid---------------0000000701.00K653.00K378.00K378.00K1.59M6.94M2.07M2.34M
FCF to OCF100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%102.03%114.89%101.92%109.40%104.72%101.04%96.50%88.42%52.35%81.43%91.23%90.69%84.01%64.93%85.91%85.37%80.78%80.78%55.08%81.59%88.46%65.13%
Dividend Paid to FCF---------------0.00%0.00%0.00%0.00%0.00%0.00%0.00%4.59%4.17%5.88%5.88%42.17%69.73%19.67%35.14%

Earnings

Report DateMar 31, 2001Jun 30, 2001Sep 30, 2001Mar 31, 2002Jun 30, 2002May 20, 2003Aug 14, 2003Nov 14, 2003Mar 3, 2004Nov 12, 2004Mar 2, 2005May 17, 2005Aug 22, 2005Nov 13, 2005Feb 13, 2006May 15, 2006Aug 22, 2006Nov 13, 2006Feb 11, 2007May 14, 2007Oct 12, 2007Feb 15, 2008May 14, 2008Nov 18, 2008Feb 13, 2009May 18, 2009Nov 13, 2009Feb 16, 2010May 14, 2010Sep 16, 2010Nov 9, 2010Feb 14, 2011May 17, 2011Sep 29, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Feb 7, 2013May 9, 2013Sep 12, 2013Nov 7, 2013Feb 6, 2014May 6, 2014Sep 10, 2014Nov 6, 2014Feb 4, 2015May 6, 2015Sep 1, 2015Nov 4, 2015Feb 9, 2016May 4, 2016Sep 6, 2016Dec 12, 2016Feb 8, 2017May 10, 2017Sep 7, 2017Nov 8, 2017Feb 7, 2018May 9, 2018Aug 15, 2018Nov 1, 2018Feb 4, 2019May 1, 2019Aug 14, 2019Oct 30, 2019Jan 28, 2020May 5, 2020Aug 18, 2020Nov 3, 2020Feb 2, 2021Apr 29, 2021Aug 19, 2021Nov 4, 2021Feb 1, 2022May 3, 2022Aug 23, 2022Nov 2, 2022Feb 2, 2023May 4, 2023Aug 28, 2023Nov 9, 2023Jan 30, 2024May 2, 2024Aug 28, 2024Oct 29, 2024Feb 5, 2025May 6, 2025Sep 4, 2025Nov 4, 2025Feb 4, 2026May 6, 2026Aug 27, 2026Nov 3, 2026
EPS Estimate-----------------0.21-0.35-0.28-0.49-0.21------------------0.350.35-0.140.140.280.140.190.210.210.070.070.230.21-0.00----------0.140.170.120.160.160.190.160.220.200.200.210.240.110.140.150.050.150.200.150.040.160.210.150.130.140.200.190.150.160.150.03
EPS Actual-0.02-0.04-0.04-0.02-0.02-0.02-0.02-0.02-0.03-14.28-0.49-4.362.470.02-0.18-0.21-0.49-0.28-0.56-0.21-0.14-0.13-0.19-0.04-0.16-0.840.13-0.08-1.01-0.560.060.42-0.93-3.920.33-0.350.270.210.010.210.210.200.210.210.140.140.420.070.080.040.110.070.150.080.130.000.020.010.060.110.120.200.070.130.120.260.130.310.130.280.250.250.200.310.230.050.120.010.06-0.070.080.170.130.100.210.140.150.220.260.170.180.150.120.11-
Surprise-----------------133.33%20.00%-100.00%57.14%33.33%-------------------40.00%-40.00%242.00%50.00%-25.00%0.00%-26.32%100.00%-66.67%14.29%-42.86%-52.17%-66.67%-------------14.29%52.94%8.33%93.75%-18.75%47.37%56.25%13.64%0.00%55.00%9.52%-79.17%9.09%-92.86%-60.00%-240.00%-46.67%-15.00%-13.33%150.00%31.25%-33.33%0.00%69.23%85.71%-15.00%-5.26%0.00%-25.00%-26.67%-
Timing-----------------Pre-marketAfter-hoursPre-market-------------------After-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hours----After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap77.93M
Enterprise Value71.87M
Trailing P/E15.47
Forward P/E37.45
PEG Ratio0.36
Price / Sales0.43
Price / Book2.29
EPS0.40
Book Value2.68
Revenue (TTM)182.59M
Gross Profit (TTM)141.61M
EBITDA9.47M
Profit Margin2.78%
Operating Margin3.93%
Return on Equity14.87%
Return on Assets6.25%
Shares Outstanding12.59M
Shares Float9.09M
Beta0.76
Dividend Yield3.19%
Dividend Rate0.20
Payout Ratio33.93%

Analyst Ratings

Strong Buy
Based on 1 analystsTarget 7.50
  • Strong Buy
    1

Ownership Breakdown

Institutions
53.67%
Insiders
12.55%
Retail / Other
33.78%

Top Institutional Holders

  • Capital Management Corp
    1.88M14.99%
  • Renaissance Technologies Corp
    867.70K6.93%
  • BlackRock Inc
    769.70K6.14%
  • Vanguard Capital Management, LLC
    429.42K3.43%
  • Geode Capital Management, LLC
    261.19K2.08%
  • Dimensional Fund Advisors, Inc.
    256.30K2.05%
  • The Goldman Sachs Group Inc
    185.11K1.48%
  • State Street Corp
    167.14K1.33%
  • AQR Capital Management LLC
    156.10K1.25%
  • American Century Companies Inc
    144.39K1.15%
  • Advyzon Investment Management, LLC
    108.25K0.86%
  • Citadel Advisors Llc
    99.79K0.80%
  • Morgan Stanley - Brokerage Accounts
    91.74K0.73%
  • Northern Trust Corp
    91.12K0.73%
  • Indivisible Partners
    84.19K0.67%
  • Perkins Capital Management Inc
    75.46K0.60%
  • Millennium Management LLC
    70.32K0.56%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    307.74K2.45%
  • Avantis US Small Cap Value ETF
    225.35K1.79%
  • DFA US Small Cap I
    72.73K0.58%

Dividends

20263×
0.05Sep 1, 20260.05Jun 1, 20260.04Mar 2, 2026
20254×
0.04Dec 1, 20250.04Sep 8, 20250.04May 30, 20250.04Mar 3, 2025
20244×
0.04Dec 2, 20240.04Sep 9, 20240.04May 31, 20240.04Feb 29, 2024
20234×
0.04Nov 30, 20230.43Sep 7, 20230.04May 31, 20230.03Feb 28, 2023
20223×
0.03Nov 30, 20220.03Sep 1, 20220.03May 16, 2022

Stock Splits

  • Oct 19, 20151:7
  • Oct 5, 20041:68